ClinicalTrials.Veeva

Menu

The Association Between Calretinin and the Function of Ganglion Cells in Hirschsprung Disease

S

St. Justine's Hospital

Status

Unknown

Conditions

Hirschsprung Disease
Hypoganglionosis
Ganglion
Hirschsprung Disease, Long-Segment

Treatments

Diagnostic Test: Calretinin staining

Study type

Observational

Funder types

Other

Identifiers

NCT04149093
2020-2597

Details and patient eligibility

About

This study aims to compare the outcomes of patients with long segment Hirschsprung disease or total colonic aganglionosis who had negative calretinin staining and positive ganglion cells on the proximal resection margins to those who had both positive findings.

Enrollment

50 estimated patients

Sex

All

Ages

Under 18 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed histopathological diagnosis of Hirschsprung disease from January 1, 1990 to August 31, 2019
  • Long-segment Hirschsprung disease (type A and B)
  • Total colonic aganglionosis (TCA)
  • Surgery at CHUSJ
  • Tissue blocks of proximal resection margin available for pathological analysis
  • Minimum 1 month of postoperative follow-up

Exclusion criteria

  • Short-segment Hirschsprung disease (conventional form, rectosigmoid junction)
  • Total colonic with small bowel aganglionosis (TCSA)
  • Surgery done at another institution
  • Early deaths
  • Lost to follow-up
  • No documented post-operative outcome

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems